Corporate Banner
Satellite Banner
Genomics
Scientific Community
 
Become a Member | Sign in
Home>Resources>Application Notes>This Application Note
  Application Notes
Scientific News
Gene Terapy for Muscle Wasting Developed
New gene therapy could save millions of people suffering from muscle wasting disease.
Gene-Editing 'Toolbox' Targets Multiple Genes Simultaneously
Researchers have designed a system that modifies, or edits, multiple genes in a genome at once while minimising unintentional effects.
Discovering the First Farmers
Genetic analyses reveal a collection of highly distinct groups in the Near East and Europe at the dawn of agriculture.
Fighting Cancer Through Protein Pathways
Researchers have found a new drug target within a protein production pathway critical to regulating growth and proliferation of cells.
Mutations in DNA-Repair Genes Found in Advanced Prostate Cancers
New findings indicate that nearly 12% of male advanced prostate cancer sufferers have inherited mutation in DNA-repair genes.
Ice Bucket Challenge Instrumental in Gene Discovery
Donations from the ALS Ice Bucket Chellenge allowed for the largest-ever study of inherited ALS, which identified a new ALS gene.
Triple-Action Therapy Patch Shows Promise
Patch that delivers drug, gene, and light-based therapy to tumor sites shows promising results in mice.
Cancer Gene-Drug Combinations Ripe for Precision Medicine
The study aims to expand the number of cancer gene mutations that can be paired with a precision therapy.
Targeting BRAF Mutations in Thyroid Cancer
Treating metastatic thyroid cancer patients harboring a BRAF mutation with vemurafenib showed anti-tumor activity in a third of patients.
Colon Cancer Blocked in Mice
Case Western Reserve University Researchers block common type of colon cancer tumour in mice, laying groundwork for human clinical trial.
Scroll Up
Scroll Down

Analysis of Recombinant Human Erythropoietin on deltaDOT’s CE platform
Bookmark and Share

deltaDOT

Recombinant Erythropoietin (EPO) has uses in legitimate treatment of disease such as anaemia, but has become notorious for its use in blood doping in endurance sports. The glycoform fingerprint obtained by this analysis, using the Peregrine High Performance Capillary Electrophoresis system and deltaDOT’s proprietary LFII™ technology, gives high quality reproducible data in terms of peak mobility (< 2 % R.S.D.) and peak area (<2 % R.S.D.). This can be potentially used to identify individual vendors formulations as well as misuse.

Further Information

Related Content

deltaDOT Announces Manufacturer for 1D Protein/Nucleic Acid Analysis System
The Peregrine Protein/Nucleic Acid analysis system and the Merlin DNA sequencer are designed to offer unrivalled sensitivity, ultra high-speed throughput and low running costs.
Thursday, September 08, 2005
Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,300+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,900+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!